Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Exclusive Article The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Written by Chris Markoch. Publication Date: 1/18/2026. 
Article Highlights - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. Buyers often target companies with disruptive technologies, exposure to emerging trends, or compelling turnaround stories. Many of these companies will never scale or survive, but if even one succeeds, investors can see outsized returns. For investors who prefer to follow the crowd, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. That isn't a guarantee of success, but it can help investors gain conviction in a stock's potential. A major force in the crypto world is quietly becoming one of gold's most aggressive buyers — and most investors have no idea it's happening.
A longtime gold analyst says profits from a leading stablecoin operation are being funneled into physical gold at a scale that could materially impact supply and demand. After a recent meeting with insiders, he began outlining what this trend could mean for gold prices and a small group of companies positioned to benefit. Read the full gold briefing here Some investors define a penny stock as any stock trading at $5 or less. The stocks in this screener follow the traditional definition: shares priced below $1. These securities are highly volatile—do your own research and know your risk tolerance before opening a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases such as influenza, norovirus, and COVID-19. Unlike traditional injected vaccines, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility. The bull case for Vaxart rests on its innovative delivery method. If the company secures FDA approval and scales production, oral vaccines could reduce logistical barriers to mass immunization and create licensing opportunities. Positive trial results or a commercial collaboration could materially change sentiment and valuation given the stock's current low base. Clinical risk is the main challenge: Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also constrains visibility. For now, Vaxart is a speculative, longer-term bet on platform validation rather than near-term profitability. MarketBeat analyst coverage for Vaxart is limited to a single analyst, which is not uncommon but should give investors pause. The company shows just 18% institutional ownership. On the positive side, the stock has only about 2% short interest, which may moderate some volatility. Microvision: Developing Cost-Effective LiDAR Units for Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors used in autonomous vehicles, smart infrastructure, and industrial sensing. Its hardware and software enable precise 3D mapping needed for self-driving and advanced driver-assistance systems (ADAS). Microvision is focused on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case for Microvision depends on continued progress toward vehicle automation and potential partnerships with major automakers. If the company can demonstrate performance or cost advantages, it could land supply agreements or licensing deals that improve revenue visibility. Microvision's technology also has applications in robotics and smart-city infrastructure, adding optionality to its growth story. Still, Microvision faces stiff competition from LiDAR players like Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). The path to profitability is uncertain, and repeated delays in commercial LiDAR adoption have frustrated investors. MVIS is covered by three analysts and carries a consensus price target of $2.50, a 169% premium to its Jan. 15 closing price. Like many speculative names, Microvision has relatively low institutional ownership (around 30%) and high short interest (around 21%), which can contribute to pronounced volatility. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization, and digital asset management. The company helps organizations convert raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain, and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems miss. The bullish thesis for Datavault AI is its niche focus and potential scalability. As data becomes an increasingly valuable commodity, businesses—and potentially individuals—are looking for ways to safely monetize digital information. Datavault's technology could benefit from broader AI adoption and growing interest in data sovereignty. Early traction or strategic partnerships could catalyze investor confidence. Datavault AI remains highly experimental. Its business model is evolving and the path to meaningful revenue is unproven. Institutional ownership is under 1%, and short interest exceeds 16% at the time of writing. Investors should treat DVLT as a long-term, speculative play on the idea of data-as-an-asset rather than a near-term earnings story.
| 
